3-chloro-N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]cyclopentanecarboxamide;[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-(4-methylpiperidin-1-yl)methanone;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-4-morpholin-4-ylbenzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide

C135H158ClN27O7 — CID 160503466

IUPAC3-chloro-N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]cyclopentanecarboxamide;[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-(4-methylpiperidin-1-yl)methanone;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-4-morpholin-4-ylbenzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide
SMILESCC1CCN(C(=O)c2ccc(CCc3[nH]nc4ccnc(NC5CCCCC5)c34)cc2)CC1.O=C(Nc1cccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)c1)C1CCCC1.O=C(Nc1cccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)c1)c1ccc(N2CCOCC2)cc1.O=C(Nc1cccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)c1)c1cccc(Cl)c1.O=C(Nc1cccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)c1)c1cocn1
InChIInChI=1S/C31H36N6O2.C27H28ClN5O.C27H35N5O.C26H33N5O.C24H26N6O2/c38-31(23-10-12-26(13-11-23)37-17-19-39-20-18-37)34-25-8-4-5-22(21-25)9-14-27-29-28(36-35-27)15-16-32-30(29)33-24-6-2-1-3-7-24;28-20-8-5-7-19(17-20)27(34)31-22-11-4-6-18(16-22)12-13-23-25-24(33-32-23)14-15-29-26(25)30-21-9-2-1-3-10-21;1-19-14-17-32(18-15-19)27(33)21-10-7-20(8-11-21)9-12-23-25-24(31-30-23)13-16-28-26(25)29-22-5-3-2-4-6-22;32-26(19-8-4-5-9-19)29-21-12-6-7-18(17-21)13-14-22-24-23(31-30-22)15-16-27-25(24)28-20-10-2-1-3-11-20;31-24(21-14-32-15-26-21)28-18-8-4-5-16(13-18)9-10-19-22-20(30-29-19)11-12-25-23(22)27-17-6-2-1-3-7-17/h4-5,8,10-13,15-16,21,24H,1-3,6-7,9,14,17-20H2,(H,32,33)(H,34,38)(H,35,36);4-8,11,14-17,21H,1-3,9-10,12-13H2,(H,29,30)(H,31,34)(H,32,33);7-8,10-11,13,16,19,22H,2-6,9,12,14-15,17-18H2,1H3,(H,28,29)(H,30,31);6-7,12,15-17,19-20H,1-5,8-11,13-14H2,(H,27,28)(H,29,32)(H,30,31);4-5,8,11-15,17H,1-3,6-7,9-10H2,(H,25,27)(H,28,31)(H,29,30)
InChIKeyQSCALOWRCHYOJH-UHFFFAOYSA-N
MW2306.38 g/mol
LogP27.67
Rot. Bonds35

About 3-chloro-N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]cyclopentanecarboxamide;[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-(4-methylpiperidin-1-yl)methanone;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-4-morpholin-4-ylbenzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide

3-chloro-N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]cyclopentanecarboxamide;[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-(4-methylpiperidin-1-yl)methanone;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-4-morpholin-4-ylbenzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide (PubChem CID 160503466) has the molecular formula C135H158ClN27O7 and a molecular weight of 2306.38 g/mol. Its IUPAC name is 3-chloro-N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]cyclopentanecarboxamide;[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-(4-methylpiperidin-1-yl)methanone;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-4-morpholin-4-ylbenzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide.

Molecular Properties

Compound Name3-chloro-N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]cyclopentanecarboxamide;[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-(4-methylpiperidin-1-yl)methanone;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-4-morpholin-4-ylbenzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide
PubChem CID160503466
Molecular FormulaC135H158ClN27O7
Molecular Weight2306.38 g/mol
Exact Mass2304.25
IUPAC Name3-chloro-N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]cyclopentanecarboxamide;[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-(4-methylpiperidin-1-yl)methanone;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-4-morpholin-4-ylbenzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide
SMILESCC1CCN(C(=O)c2ccc(CCc3[nH]nc4ccnc(NC5CCCCC5)c34)cc2)CC1.O=C(Nc1cccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)c1)C1CCCC1.O=C(Nc1cccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)c1)c1ccc(N2CCOCC2)cc1.O=C(Nc1cccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)c1)c1cccc(Cl)c1.O=C(Nc1cccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)c1)c1cocn1
InChIInChI=1S/C31H36N6O2.C27H28ClN5O.C27H35N5O.C26H33N5O.C24H26N6O2/c38-31(23-10-12-26(13-11-23)37-17-19-39-20-18-37)34-25-8-4-5-22(21-25)9-14-27-29-28(36-35-27)15-16-32-30(29)33-24-6-2-1-3-7-24;28-20-8-5-7-19(17-20)27(34)31-22-11-4-6-18(16-22)12-13-23-25-24(33-32-23)14-15-29-26(25)30-21-9-2-1-3-10-21;1-19-14-17-32(18-15-19)27(33)21-10-7-20(8-11-21)9-12-23-25-24(31-30-23)13-16-28-26(25)29-22-5-3-2-4-6-22;32-26(19-8-4-5-9-19)29-21-12-6-7-18(17-21)13-14-22-24-23(31-30-22)15-16-27-25(24)28-20-10-2-1-3-11-20;31-24(21-14-32-15-26-21)28-18-8-4-5-16(13-18)9-10-19-22-20(30-29-19)11-12-25-23(22)27-17-6-2-1-3-7-17/h4-5,8,10-13,15-16,21,24H,1-3,6-7,9,14,17-20H2,(H,32,33)(H,34,38)(H,35,36);4-8,11,14-17,21H,1-3,9-10,12-13H2,(H,29,30)(H,31,34)(H,32,33);7-8,10-11,13,16,19,22H,2-6,9,12,14-15,17-18H2,1H3,(H,28,29)(H,30,31);6-7,12,15-17,19-20H,1-5,8-11,13-14H2,(H,27,28)(H,29,32)(H,30,31);4-5,8,11-15,17H,1-3,6-7,9-10H2,(H,25,27)(H,28,31)(H,29,30)
InChIKeyQSCALOWRCHYOJH-UHFFFAOYSA-N
XLogP27.67
TPSA443.21 Ų
H-Bond Donors14
H-Bond Acceptors24
Rotatable Bonds35
Heavy Atoms170
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002306.38
LogP ≤ 527.67
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1024

Analyze 3-chloro-N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]cyclopentanecarboxamide;[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-(4-methylpiperidin-1-yl)methanone;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-4-morpholin-4-ylbenzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-chloro-N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]cyclopentanecarboxamide;[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-(4-methylpiperidin-1-yl)methanone;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-4-morpholin-4-ylbenzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide?
The IUPAC name of 3-chloro-N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]cyclopentanecarboxamide;[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-(4-methylpiperidin-1-yl)methanone;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-4-morpholin-4-ylbenzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide (CID 160503466) is 3-chloro-N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]cyclopentanecarboxamide;[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-(4-methylpiperidin-1-yl)methanone;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-4-morpholin-4-ylbenzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide.
What is the SMILES notation for 3-chloro-N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]cyclopentanecarboxamide;[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-(4-methylpiperidin-1-yl)methanone;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-4-morpholin-4-ylbenzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide?
The canonical SMILES for 3-chloro-N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]cyclopentanecarboxamide;[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-(4-methylpiperidin-1-yl)methanone;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-4-morpholin-4-ylbenzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide is CC1CCN(C(=O)c2ccc(CCc3[nH]nc4ccnc(NC5CCCCC5)c34)cc2)CC1.O=C(Nc1cccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)c1)C1CCCC1.O=C(Nc1cccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)c1)c1ccc(N2CCOCC2)cc1.O=C(Nc1cccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)c1)c1cccc(Cl)c1.O=C(Nc1cccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)c1)c1cocn1.
What is the InChIKey of 3-chloro-N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]cyclopentanecarboxamide;[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-(4-methylpiperidin-1-yl)methanone;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-4-morpholin-4-ylbenzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide?
The InChIKey is QSCALOWRCHYOJH-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H36N6O2.C27H28ClN5O.C27H35N5O.C26H33N5O.C24H26N6O2/c38-31(23-10-12-26(13-11-23)37-17-19-39-20-18-37)34-25-8-4-5-22(21-25)9-14-27-29-28(36-35-27)15-16-32-30(29)33-24-6-2-1-3-7-24;28-20-8-5-7-19(17-20)27(34)31-22-11-4-6-18(16-22)12-13-23-25-24(33-32-23)14-15-29-26(25)30-21-9-2-1-3-10-21;1-19-14-17-32(18-15-19)27(33)21-10-7-20(8-11-21)9-12-23-25-24(31-30-23)13-16-28-26(25)29-22-5-3-2-4-6-22;32-26(19-8-4-5-9-19)29-21-12-6-7-18(17-21)13-14-22-24-23(31-30-22)15-16-27-25(24)28-20-10-2-1-3-11-20;31-24(21-14-32-15-26-21)28-18-8-4-5-16(13-18)9-10-19-22-20(30-29-19)11-12-25-23(22)27-17-6-2-1-3-7-17/h4-5,8,10-13,15-16,21,24H,1-3,6-7,9,14,17-20H2,(H,32,33)(H,34,38)(H,35,36);4-8,11,14-17,21H,1-3,9-10,12-13H2,(H,29,30)(H,31,34)(H,32,33);7-8,10-11,13,16,19,22H,2-6,9,12,14-15,17-18H2,1H3,(H,28,29)(H,30,31);6-7,12,15-17,19-20H,1-5,8-11,13-14H2,(H,27,28)(H,29,32)(H,30,31);4-5,8,11-15,17H,1-3,6-7,9-10H2,(H,25,27)(H,28,31)(H,29,30).
What are the key properties of 3-chloro-N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]cyclopentanecarboxamide;[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-(4-methylpiperidin-1-yl)methanone;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-4-morpholin-4-ylbenzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide?
3-chloro-N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]cyclopentanecarboxamide;[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-(4-methylpiperidin-1-yl)methanone;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-4-morpholin-4-ylbenzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide has a molecular weight of 2306.38 g/mol, XLogP of 27.67, 35 rotatable bonds, 14 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 3-chloro-N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]cyclopentanecarboxamide;[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-(4-methylpiperidin-1-yl)methanone;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-4-morpholin-4-ylbenzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide is sourced from PubChem (CID 160503466), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).